Gender and gonadal function differences in the prevalence of bone mass reduction

Abstract

The role of gender and gonadal steroids in the genesis of bone loss in HIV-infected patients has been investigated. Apart from a role of estradiol end lean mass, no other gender related variables resulted associated to bone loss in both men and women with HIV